Topics

Human medicines European public assessment report (EPAR): Vectibix, panitumumab, Revision: 28, Authorised

09:28 EST 2 Feb 2018 | European Medicines Agency
This article has expired, however you can still download the PDF.
Preview:
...

Other Sources for this Article

Original Article: Human medicines European public assessment report (EPAR): Vectibix, panitumumab, Revision: 28, Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Vectibix, panitumumab, Revision: 28, Authorised"

Quick Search